Drug Shortage Report for DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21
| Report ID | 256803 |
| Drug Identification Number | 02421437 |
| Brand name | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 |
| Common or Proper name | Drospirenone and Ethinyl Estradiol |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL DROSPIRENONE |
| Strength(s) | 0.03MG 3MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 3x21 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-04-14 |
| Estimated end date | 2025-07-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-05-07 | French | Compare |
| v1 | 2025-05-07 | English | Compare |
Showing 1 to 2 of 2